Drawing for APTASCREEN

USPTO serial 79010355

APTASCREEN

Reviewed by CopyMark Law Group

Reg. 3171662Status 404
Filing date
Status date
Registration date
Nov 14, 2006
Examiner
BLAIR, JASON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with APTASCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brooks R Bruneau

BROOKS R BRUNEAU MATTHEWS SHEPHERD MCCKAY & BRUNEAU100 THANET CIR STE 306PRINCETON, NJ 08540-3674UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; chemicals, namely, reagents, nucleic acids, proteins and peptides for scientific use; reagents for chemical analysis; biological analysis reagents for the scientific analysis of samples or extracts derived from plant, animals, and human sources; molecules, namely, organic or inorganic compounds, organic polymers, nucleic acids, lipids, peptides and proteins for in vitro scientific and research use; laboratory chemicals for scientific use and for pharmaceutical useSECTION 71 - CANCELLED—
003Cosmetics products, namely, biotechnology products containing organic polymers, nucleic acids, lipids, peptides and proteins for use in creams, ointments, solutions or gels for skin, hair, nail and eye productsSECTION 71 - CANCELLED—
005Pharmaceutical and veterinary products, namely, organic and inorganic compounds, organic polymers, nucleic acids, lipids, peptides and proteins for use in the diagnosis, prevention and treatment of diseases; namely cancer, cardiovascular disease, inflammatory disease, infectious disease, neurological disorders, metabolic disorders; hygienic products for medical use, namely, soaps, douches, shampoos, disinfectants and solutions, namely organic and inorganic compounds, organic polymers, nucleic acids, lipids, peptides and proteins in solutions, namely dissolved and suspended in aqueous and organic liquids; proteins and peptides for medical and pharmaceutical use; biotechnological products for medical and pharmaceutical use, namely, microbiological fermentations, extractions from biological sources, molecular synthesis and cell cultures; diagnostic products for medical use, namely, organic and inorganic compounds, organic polymers, nucleic acids, lipids, peptides and proteins in solutions, kits and probes comprised of organic and inorganic compounds, organic polymers, nucleic acids, lipids, peptides and proteins for the detection and measurement of markers of disease and disease risk factors and biological samples either in vivo, ex vivo or in vitro; products intended for medical or biological analysis for the diagnosis of disease, the measurement of disease risk factors, and the assessment of patients undergoing medical or surgical treatment in human and veterinary medicine, namely, organic and inorganic compounds, organic polymers, nuclear acids, lipids, peptides and proteins in solutions, kits and probes comprised of organic and inorganic compounds, organic polymers, nucleic acids, lipids, peptides and proteins for the detection and measurement of markers of disease and disease risk factors and biological samples either in vivo, ex vivo or in vitroSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 3, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Apr 3, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 21, 2014INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 13, 2014XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 13, 2014XXCRGENERIC MADRID TRANSACTION CREATED—
May 13, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 13, 2013C71TCANCELLED SECTION 71—
Mar 7, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 25, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 25, 2007FIMPFINAL DISPOSITION PROCESSED—
Jun 13, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 14, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 10, 2006OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 26, 2006OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 26, 2006OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 29, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 9, 2006NPUBNOTICE OF PUBLICATION—
Jul 6, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 30, 2006ALIEASSIGNED TO LIE—
Jun 28, 2006CNEAEXAMINERS AMENDMENT MAILED—
Jun 28, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 28, 2006XAECEXAMINER'S AMENDMENT ENTERED—
Jun 28, 2006CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 7, 2006DOCKASSIGNED TO EXAMINER—
Feb 1, 2006CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 31, 2006CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 10, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 22, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 22, 2005MAILPAPER RECEIVED—
Nov 28, 2005CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 14, 2005RFNTREFUSAL PROCESSED BY IB—
Jun 23, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 10, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 9, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2005DOCKASSIGNED TO EXAMINER—
May 27, 2005NWAPNEW APPLICATION ENTERED—
May 26, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance